Angiogenesis in wound repair: Angiogenic growth factors and the extracellular matrix

Microscopy Research and Technique

Volumn 60, Issue 1, 2003, Pages 107-114

  Li, Jie ^a   Zhang, Yan Ping ^a   Kirsner, Robert S ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Angiopoietin; Extracellular matrix; FGF; Growth factor; Integrin; Laminin; TGF ; VEGF

Indexed keywords

BLOOD VESSELS; BUILDINGS; CELL CULTURE; GRANULATION; REPAIR; TISSUE; TISSUE REGENERATION;

ANGIOGENESIS; ANGIOPOIETINS; EXTRACELLULAR MATRICES; FGF; GROWTH FACTOR; INTEGRINS; LAMININ; TGFΒ; VEGF; WOUND REPAIR;

ENDOTHELIAL CELLS;

ALPHA1 INTEGRIN; ANGIOGENIC FACTOR; ANGIOPOIETIN; BETA1 INTEGRIN; CYTOKINE; FIBROBLAST GROWTH FACTOR; INTEGRIN; INTEGRIN RECEPTOR; LAMININ; LAMININ 10; LAMININ 8; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; BASEMENT MEMBRANE; CELL MIGRATION; EXTRACELLULAR MATRIX; GRANULATION TISSUE; HUMAN; INFLAMMATORY CELL; NONHUMAN; OXYGEN TISSUE LEVEL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; SKIN CELL; TISSUE GROWTH; VASCULAR ENDOTHELIUM; WOUND HEALING;

EID: 0037223577     PISSN: 1059910X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jemt.10249     Document Type: Review

References (103)

1. Arnold F, West D, Kumar S. 1987. Wound healing: The effect of macrophage and tumor derived angiogenesis factors on skin graft vascularization. Br J Exp Pathol 68:569-574.
2. Baird A, Mormede P, Bohlen P. 1985. Immunoreactive fibroblast growth factor in cells of peritoneal exudate suggests its identity with macrophage-derived growth factor. Biochem Biophys Res Commun 126:358-364.
3. Bates DO, Curry FE. 1997. Vascular endothelial growth factor increases microvascular permeability via a Ca(2+)-dependent pathway. Am J Physiol 273:H687-694.
4. Bauer J, Margolis M, Schreiner C, Edgell CJ, Azizkhan J, Lazarowski E, Juliano RL. 1992. In vitro model of angiogenesis using a human endothelium-derived permanent cell line: Contributions of induced gene expression, G-proteins, and integrins. J Cell Physiol 153:437-449.
5. Berse B, Brown LF, Van de Water L, Dvorak HF, Senger DR. 1992. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol Biol Cell 3:211-220.
6. Blotnick S, Peoples GE, Freeman MR, Eberlein TJ, Klagsbrun M. 1994. T lymphocytes synthesize and export heparin-binding epidermal growth factor-like growth factor and basic fibroblast growth factor, mitogens for vascular cells and fibroblasts: Differential production and release by CD4+ and CD8+ T cells. Proc Natl Acad Sci USA 91:2890-2894.
7. Brooks PC, Clark RA, Cheresh DA. 1994. Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science 264:569-571.
8. Brooks PC, Stromblad S, Klemke R, Visscher D, Sarkar FH, Cheresh DA. 1995. Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin. J Clin Invest 96:1815-1822.
9. Brooks PC, Stromblad S, Sanders LC, von Schalscha TL, Aimes RT, Stetler-Stevenson WG, Quigley JP, Cheresh DA. 1996. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. Cell 85:683-693.
10. Brown LF, Yeo KT, Berse B, Yeo TK, Senger DR, Dvorak HF, van de Water L. 1992. Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J Exp Med 176:1375-1379.
11. Brown KJ, Maynes SF, Bezos A, Maguire DJ, Ford MD, Parish CR. 1996. A novel in vitro assay for human angiogenesis. Lab Invest 75:539-555.
12. Cheifetz S, Hernandez H, Laiho M, ten Dijke P, Iwata KK, Massague J. 1990. Distinct transforming growth factor-beta (TGF-beta) receptor subsets as determinants of cellular responsiveness to three TGF-beta isoforms. J Biol Chem 265:20533-20538.
13. Christofidou-Solomidou M, Bridges M, Murphy GF, Albelda SM, DeLisser HM. 1997. Expression and function of endothelial cell alpha v integrin receptors in wound-induced human angiogenesis in human skin/SCID mice chimeras. Am J Pathol 151:975-983.
14. Clark RA, Lanigan JM, DellaPelle P, Manseau E, Dvorak HF, Colvin RB. 1982. Fibronectin and fibrin provide a provisional matrix for epidermal cell migration during wound reepithelialization. J Invest Dermatol 79:264-269.
15. Clark RA, Tonnesen MG, Gailit J, Cheresh DA. 1996. Transient functional expression of alpha v beta 3 on vascular cells during wound repair. Am J Pathol 148:1407-1421.
16. Collo G, Pepper MS. 1999. Endothelial cell integrin alpha5betal expression is modulated by cytokines and during migration in vitro. J Cell Sci 112:569-578.
17. Conn G, Bayne ML, Soderman DD, Kwok PW, Sullivan KA, Palisi TM, Hope DA, Thomas KA. 1990. Amino acid and cDNA sequences of a vascular endothelial cell mitogen that is homologous to platelet-derived growth factor. Proc Natl Acad Sci USA 87:2628-2632.
18. Detmar M, Brown LF, Berse B, Jackman RW, Elicker BM, Dvorak HF, Claffey KP. 1997. Hypoxia regulates the expression of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) and its receptors in human skin. J Invest Dermatol 108:263-268.
19. de Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT. 1992. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255:989-991.
20. Dumont DJ, Yamaguchi TP, Conlon RA, Rossant J, Breitman ML. 1992. tek, a novel tyrosine kinase gene located on mouse chromosome 4, is expressed in endothelial cells and their presumptive precursors. Oncogene 7:1471-1480.
21. Enenstein J, Waleh NS, Kramer RH. 1992. Basic FGF and TGF-beta differentially modulate integrin expression of human microvascular endothelial cells. Exp Cell Res 203:499-503.
22. Esser S, Wolburg K, Wolburg H, Breier G, Kurzchalia T, Risau W. 1998. Vascular endothelial growth factor induces endothelial fenestrations in vitro. J Cell Biol 140:947-959.
23. Falcone DJ, McCaffrey TA, Haimovitz-Friedman A, Garcia M. 1993. Transforming growth factor-beta 1 stimulates macrophage urokinase expression and release of matrix-bound basic fibroblast growth factor. J Cell Physiol 155:595-605.
24. Feng X, Clark RA, Galanakis D, Tonnesen MG. 1 999. Fibrin and collagen differentially regulate human dermal microvascular endothelial cell integrins: Stabilization of alphav/beta3 mRNA by fibrin1. J Invest Dermatol 113:913-919.
25. Ferrara N. 2001. Role of vascular endothelial growth factor in regulation of physiological angiogenesis. Am J Physiol Cell Physiol. 280:C1358-1366.
26. Folkman J. 1982. Angiogenesis: Initiation and control. Ann NY Acad Sci 401:212-217.
27. Folkman J, Klagsbrun M. 1987. Angiogenic factors. Science 235:442-448.
28. Folkman J, Shing T. 1992. Angiogenesis. J Biol Chem 267:10931-10934.
29. Folkman J, Klagsbrun M, Sasse J, Wadzinski M, Ingber D, Vlodavsky I. 1988. A heparin-binding angiogenic protein - Basic fibroblast growth factor - Is stored within basement membrane. Am J Pathol 130:393-400.
30. Frank S, Madlener M, Werner S. 1996. Transforming growth factors betal, beta2, and beta3 and their receptors are differentially regulated during normal and impaired wound healing. J Biol Chem 271:10188-10193.
31. Franzen P, ten Dijke P, Ichijo H, Yamashita H, Schulz P, Heldin CH, Miyazono K. 1993. Cloning of a TGF beta type I receptor that forms a heteromeric complex with the TGF beta type II receptor. Cell 75:681-692.
32. Friesel RE, Maciag T. 1995. Molecular mechanisms of angiogenesis: Fibroblast growth factor signal transduction. FASEB J 9:919-925.
33. Fujikawa K, de Aos Scherpenseel I, Jain SK, Presman E, Christensen RA, Varticovski L. 1999. Role of PI 3-kinase in angiopoietin-1-mediated migration and attachment-dependent survival of endothelial cells. Exp Cell Res 253:663-672.
34. Gerber HP, Dixit V, Ferrara N. 1998. Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells. J Biol Chem 273:13313-13316.
35. Giancotti FG, Ruoslahti E. Integrin signaling. 1999. Science 285:1028-1032.
36. Gonzales M, Weksler B, Tsuruta D, Goldman RD, Yoon KJ, Hopkinson SB, Flitney FW, Jones JCR. 2001. Structure and function of a vimentin-associated matrix adhesion in endothelial cells. Mol Biol Cell 12:85-100.
37. Gualandris A, Presta M. 1995. Transcriptional and posttranscriptional regulation of urokinase-type plasminogen activator expression in endothelial cells by basic fibroblast growth factor. J Cell Physiol 162:400-409.
38. Haroon ZA, Hettasch JM, Lai TS, Dewhirst MW, Greenberg CS. 1999. Tissue transglutaminase is expressed, active, and directly involved in rat dermal wound healing and angiogenesis. FASEB J 13:1787-1795.
39. Hayes AJ, Huang WQ, Mallah J, Yang D, Lippman ME, Li LY. 1999. Angiopoietin-1 and its receptor Tie-2 participate in the regulation of capillary-like tubule formation and survival of endothelial cells. Microvasc Res 58:224-237.
40. Houck KA, Ferrara N, Winer J, Cachianes G, Li B, Leung DW. 1991. The vascular endothelial growth factor family: Identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol 5:1806-1814.
41. Howdieshell TR, Callaway D, Webb WL, Gaines MD, Procter CD Jr, Sathyanarayana, Pollock JS, Brock TL, McNeil PL. 2001. Antibody neutralization of vascular endothelial growth factor inhibits wound granulation tissue formation. J Surg Res 96:173-182.
42. Ingber D, Folkman J. 1988. Inhibition of angiogenesis through modulation of collagen metabolism. Lab Invest. 59:44-51.
43. Ingber DE, Prusty D, Sun Z, Betensky H, Wang N. 1995. Cell shape, cytoskeletal mechanics, and cell cycle control in angiogenesis. J Biomech 28:1471-1484.
44. Jingjing L, Xue Y, Agarwal N, Roque RS. 1999. Human Muller cells express VEGF183, a novel spliced variant of vascular endothelial growth factor. Invest Ophthalmol Vis Sci 40:752-759.
45. Jones JC, Dehart GW, Gonzales M, Goldfinger LE. 2000. Laminins: An overview. Microsc Res Tech 51:211-213.
46. Kalebic T, Garbisa S, Glaser B, Liotta LA. 1983. Basement membrane collagen: Degradation by migrating endothelial cells. Science 221:281.
47. Kampfer H, Pfeilschifter J, Frank S. 2001. Expressional regulation of angiopoietin-1 and -2 and the tie-1 and -2 receptor tyrosine kinases during cutaneous wound healing: A comparative study of normal and impaired repair. Lab Invest 81:361-373.
48. Kanda S, Landgren E, Ljungstrom M, Claesson-Welsh L. 1996. Fibroblast growth factor receptor 1 induced differentiation of endothelial cell line established from tsA58 large T transgenic mice. Cell Growth Differ 7:383-395.
49. Kandel J, Bossy-Wetzel E, Radvanyi F, Klagsbrun M, Folkman J, Hanahan D. 1991. Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma. Cell 66:1095-1104.
50. Keck PJ, Hauser SD, Krivi G, Sanzo K, Warren T, Feder J, Connolly DT. 1989. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 246:1309-1313.
51. Kim KY, Jeong SY, Won J, Ryu PD, Nam MJ. 2001. Induction of angiogenesis by expression of soluble type II transforming growth factor-beta receptor in mouse hepatoma. J Biol Chem 276:38781- 38786.
52. Kingsley DM. 1994. The TGF-beta superfamily: New members, new receptors, and new genetic tests of function in different organisms. Genes Dev 8:133-146.
53. Kishimoto J, Ehama R, Ge Y, Kobayashi T, Nishiyama T, Detmar M, Burgeson RE. 2000. In vivo detection of human vascular endothelial growth factor promoter activity in transgenic mouse skin. Am J Pathol 157:103-110.
54. Larsson J, Goumans MJ, Sjostrand LJ, van Rooijen MA, Ward D, Leveen P, Xu X, ten Dijke P, Mummery CL, Karlsson S. 2001. Abnormal angiogenesis but intact hematopoietic potential in TGF-beta type I receptor-deficient mice. EMBO J 20:1663-1673.
55. Li J, Foitzik K, Calautti E, Baden H, Doetschman T, Dotto GP. 1999. TGF-beta3, but not TGF-beta1, protects keratinocytes against 12O-tetradecanoylphorbol-13-acetate-induced cell death in vitro and in vivo. J Biol Chem 274:4213-4219.
56. Lin HY, Wang XF, Ng-Eaton E, Weinberg RA, Lodish HF. 1992. Expression cloning of the TGF-beta type II receptor, a functional transmembrane serine/threonine kinase. Cell 68:775-785.
57. Madri JA, Bell L, Marx M, Merwin JR, Basson C, Prinz C. 1991. Effects of soluble factors and extracellular matrix components on vascular cell behavior in vitro and in vivo: Models of de-endothelialization and repair. J Cell Biochem 45:123-130.
58. Madri JA, Marx M. 1992. Matrix composition, organization and soluble factors: Modulators of microvascular cell differentiation in vitro. Kidney Int 41:560-565.
59. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, Daly TJ, Davis S, Sato TN, Yancopoulos GD. 1997. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277:55-60.
60. Marx M, Perlmutter R, Madri JA. 1994. Modulation of PDGF-receptor expression in microvascular endothelial cells during in vitro angiogenesis. J Clin Invest 93:131-139.
61. Massague J, Chen YG. 2000. Controlling TGF-beta signaling. Genes Dev 14:627-644.
62. McNeil PL, Muthukrishnan L, Warder E, D'Amore PA. 1989. Growth factors are released by mechanically wounded endothelial cells. J Cell Biol 109:811-822.
63. Merwin JR, Anderson JM, Kocher O, Van Itallie CM, Madri JA. 1990. Transforming growth factor beta 1 modulates extracellular matrix organization and cell-cell junctional complex formation during in vitro angiogenesis. J Cell Physiol 142:117-128.
64. Millauer B, Wizigmann-Voos S, Schnurch H, Martinez R, Moller NP, Risau W, Ullrich A. 1993, High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator ofvasculogenesis and angiogenesis. Cell 72:835-846.
65. Nakamura T, Mochizuki Y, Kanetake H, Kanda S. 2001. Signals via FGF receptor 2 regulate migration of endothelial cells. Biochem Biophys Res Commun 289:801-806.
66. Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z. 1999. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 13:9-22.
67. Nicosia RF, Bonanno E, Smith M, Yurchenco P. 1994. Modulation of angiogenesis in vitro by laminin entactin complex. Dev Biol 164:197-206.
68. Nissen NN, Polverini PJ, Koch AE, Volin MV, Gamelli RL, DiPietro LA. 1998. Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing. Am J Pathol 152:1445-1452.
69. O'Kane S, Ferguson MW. 1997. Transforming growth factor beta s and wound healing. Int J Biochem Cell Biol 29:63-78.
70. Papapetropoulos A, Fulton D, Mahboubi K, Kalb RG, O'Connor DS, Li F, Altieri DC, Sessa WC. 2000. Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt/survivin pathway. J Biol Chem 275:9102-9105.
71. Park JE, Keller GA, Ferrara N. 1993. The vascular endothelial growth factor (VEGF) isoforms: Differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. Mol Biol Cell 4:1317-1326.
72. Partanen J, Armstrong E, Makela TP, Korhonen J, Sandberg M, Renkonen R, Knuutila S, Huebner K, Alitalo K. 1992a. A novel endothelial cell surface receptor tyrosine kinase with extracellular epidermal growth factor homology domains. Mol Cell Biol 12:1698-1707.
73. Partanen J, Vainikka S, Korhonen J, Armstrong E, Alitalo K. 1992b. Diverse receptors for fibroblast growth factors. Prog Growth Factor Res 4:69-83.
74. Peters KG, Werner S, Chen G, Williams LT. 1992. Two FGF receptor genes are differentially expressed in epithelial and mesenchymal tissues during limb formation and organogenesis in the mouse. Development 114:233-243.
75. Poltorak Z, Cohen T, Sivan R, Kandelis Y, Spira G, Vlodavsky I, Keshet E, Neufeld G. 1997. VEGF 145, a secreted vascular endothelial growth factor isoform that binds to extracellular matrix. J Biol Chem. 272:7151-7158.
76. Procopio WN, Pelavin PI, Lee WM, Yeilding NM. 1999. Angiopoietin-1 and -2 coiled coil domains mediate distinct homo-oligomelization patterns, but fibrinogen-like domains mediate ligand activity. J Biol Chem 274:30196-30201.
77. Remensnyder JP, Majno G. 1968. Oxygen gradients in healing wounds. Am J Pathol 52:301-323.
78. Risau W. Mechanisms of angiogenesis. 1997. Nature 386:671-674.
79. Roberts AB, Sporn MB, Assoian RK, Smith JM, Roche NS, Wakefield LM, Heine UI, Liotta LA, Falanga V, Kehrl JH, Fauci AS. 1986. Transforming growth factor type beta: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 83:4167-4171.
80. Roesel JF, Nanney LB. 1995. Assessment of differential cytokine effects on angiogenesis using an in vivo model of cutaneous wound repair. J Surg Res 58:449-459.
81. Ruoslahti E, Yamaguchi Y. 1991. Proteoglycans as modulators of growth factor activities. Cell 64:867-869.
82. Sanchez-Elsner T, Botella LM, Velasco B, Corbi A, Attisano L, Bernabeu C. 2001. Synergistic cooperation between hypoxia and transforming growth factor-beta pathways on human vascular endothelial growth factor gene expression. J Biol Chem 276:38527-38535.
83. Sankar S, Mahooti-Brooks N, Bensen L, McCarthy TL, Centrella M, Madri JA. 1996. Modulation of transforming growth factor beta receptor levels on microvascular endothelial cells during in vitro angiogenesis. J Clin Invest 97:1436-1446.
84. Sano H, Forough R, Maier JA, Case JP, Jackson A, Engleka K, Maciag T, Wilder RL. 1990. Detection of high levels of heparin binding growth factor-1 (acidic fibroblast growth factor) in inflammatory arthritic joints. J Cell Biol 110:1417-1426.
85. Schweigerer L, Neufeld G, Friedman J, Abraham JA, Fiddes JC, Gospodarowicz D. 1987. Capillary endothelial cells express basic fibroblast growth factor, a mitogen that promotes their own growth. Nature 325:257-259.
86. Senger DR, Ledbetter SR, Claffey KP, Papadopoulos-Sergiou A, Peruzzi CA, Detmar M. 1996. Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the alphavbeta3 integrin, osteopontin, and thrombin. Am J Pathol 149:293-305.
87. Senger DR, Claffey KP, Benes JE, Perruzzi CA, Sergiou AP, Detmar M. 1997. Angiogenesis promoted by vascular endothelial growth factor: Regulation through alphalbetal and alpha2betal integrins. Proc Natl Acad Sci USA 94:13612-13617.
88. Seno M, Sasada R, Kurokawa T, Igarashi K. 1990. Carboxyl-terminal structure of basic fibroblast growth factor significantly contributes to its affinity for heparin. Eur J Biochem 188:239-245.
89. Sephel GC, Kennedy R, Kudravi S. 1996. Expression of capillary basement membrane components during sequential phases of wound angiogenesis. Matrix Biol 15:263-279.
90. Sepp NT, Li LJ, Lee KH, Brown EJ, Caughman SW, Lawley TJ, Swerlick RA. 1994. Basic fibroblast growth factor increases expression of the alpha v beta 3 integrin complex on human microvascular endothelial cells. J Invest Dermatol 103:295-299.
91. Sonnenberg A, Modderman PW, Hogervorst F. 1988. Laminin receptor on platelets is the integrin VLA-6. Nature 336:487-489.
92. Suri C, Jones PF, Patan S, Bartunkova S, Maisonpierre PC, Davis S, Sato TN, Yancopoulos GD. 1996. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87:1171-1180.
93. Suri C, McClain J, Thurston G, McDonald DM, Zhou H, Oldmixon EH, Sato TN, Yancopoulos GD. 1998. Increased vascularization in mice overexpressing angiopoietin-1. Science 282:468-471.
94. Taipale J, Keski-Oja J. 1996. Hepatocyte growth factor releases epithelial and endothelial cells from growth arrest induced by transforming growth factor-beta1. J Biol Chem 271:4342-4348.
95. Tani T, Lehto VP, Virtanen I. 1999. Expression of laminins 1 and 10 in carcinoma cells and comparison of their roles in cell adhesion. Exp Cell Res 248:115-121.
96. Thurston G, Suri C, Smith K, McClain J, Sato TN, Yancopoulos GD, McDonald DM. 1999. Leakage resistant blood vessels in mice transgenically overexpressing angi opoietin-1. Science 286:2511-2514.
97. Tischer E, Mitchell R, Hartman T, Silva M, Gospodarowicz D, Fiddes JC, Abraham JA. 1991. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing, J Biol Chem. 266:11947-11954.
98. Trompezinski S, Pernet I, Mayoux C, Schmitt D, Viac J. 2000. Transforming growth factor-β1 and ultraviolet A1 radiation increase production of vascular endothleial growth factor but not endothelin-1 in human dermal fibroblasts. Br J Dermatol 143:539-545.
99. Yang EY, Moses HL. 1990. Transforming growth factor-β1-induced migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane. J Cell Biol 111:731-741.
100. Vlodavsky I, Folkman J, Sullivan R, Fridman R, Ishai-Michaeli R, Sasse J, Klagsbrun M. 1987. Endothelial cell-derived basic fibroblast growth factor: Synthesis and deposition into subendothelial extracellular matrix. Proc Natl Acad Sci USA 84:2292-2296.
101. Welch MP, Odland GF, Clark RA. 1990. Temporal relationships of F-actin bundle formation, collagen and fibronectin matrix assembly, and fibronectin receptor expression to wound contraction. J Cell Biol 110:133-145.
102. Witt DP, Lander AD. 1994. Differential binding of chemokines to glycosaminoglycan subpopulations. Curr Biol 4:394-400.
103. Wong AL, Haroon ZA, Werner S, Dewhirst MW, Greenberg CS, Peters KG. 1997. Tie2 expression and phosphorylation in angiogenic and quiescent adult tissues. Circ Res 81:567-574.